• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

KLHL6 的缺失通过稳定 mRNA 降解因子 roquin2 促进弥漫性大 B 细胞淋巴瘤的生长和存活。

Loss of KLHL6 promotes diffuse large B-cell lymphoma growth and survival by stabilizing the mRNA decay factor roquin2.

机构信息

Department of Cancer Biology, University of Pennsylvania, Philadelphia, PA, USA.

Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

出版信息

Nat Cell Biol. 2018 May;20(5):586-596. doi: 10.1038/s41556-018-0084-5. Epub 2018 Apr 25.

DOI:10.1038/s41556-018-0084-5
PMID:29695787
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5926793/
Abstract

Kelch-like protein 6 (KLHL6) is an uncharacterized gene mutated in diffuse large B-cell lymphoma (DLBCL). Here we report that KLHL6 assembles with cullin3 to form a functional cullin-RING ubiquitin ligase. Mutations in KLHL6 inhibit its ligase activity by disrupting the interaction with cullin3. Loss of KLHL6 favours DLBCL growth and survival both in vitro and in xenograft models. We further established that the mRNA decay factor roquin2 is a substrate of KLHL6. Degradation of roquin2 is dependent on B-cell receptor activation, and requires the integrity of the Tyr691 residue in roquin2 that is essential for its interaction with KLHL6. A non-degradable roquin2(Y691F) mutant requires its RNA-binding ability to phenocopy the effect of KLHL6 loss. Stabilization of roquin2 promotes mRNA decay of the tumour suppressor and NF-κB pathway inhibitor, tumour necrosis factor-α-inducible gene 3. Collectively, our findings uncover the tumour suppressing mechanism of KLHL6.

摘要

Kelch 样蛋白 6(KLHL6)是弥漫性大 B 细胞淋巴瘤(DLBCL)中突变的未鉴定基因。在这里,我们报告 KLHL6 与 cullin3 组装形成功能性 cullin-RING 泛素连接酶。KLHL6 中的突变通过破坏与 cullin3 的相互作用来抑制其连接酶活性。KLHL6 的缺失有利于体外和异种移植模型中 DLBCL 的生长和存活。我们进一步确定 mRNA 降解因子 roquin2 是 KLHL6 的底物。roquin2 的降解依赖于 B 细胞受体的激活,并且需要 roquin2 中 Tyr691 残基的完整性,该残基对于其与 KLHL6 的相互作用至关重要。不可降解的 roquin2(Y691F)突变体需要其 RNA 结合能力来模拟 KLHL6 缺失的效果。roquin2 的稳定化促进肿瘤抑制因子和 NF-κB 途径抑制剂肿瘤坏死因子-α诱导基因 3 的 mRNA 降解。总之,我们的发现揭示了 KLHL6 的肿瘤抑制机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ec8/5926793/969145db710e/nihms951082f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ec8/5926793/00668dbafb6a/nihms951082f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ec8/5926793/d7c50c1be84d/nihms951082f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ec8/5926793/f86864568f22/nihms951082f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ec8/5926793/68beaf80c6a0/nihms951082f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ec8/5926793/92795c6e4a0a/nihms951082f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ec8/5926793/134fbfac7f5f/nihms951082f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ec8/5926793/969145db710e/nihms951082f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ec8/5926793/00668dbafb6a/nihms951082f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ec8/5926793/d7c50c1be84d/nihms951082f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ec8/5926793/f86864568f22/nihms951082f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ec8/5926793/68beaf80c6a0/nihms951082f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ec8/5926793/92795c6e4a0a/nihms951082f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ec8/5926793/134fbfac7f5f/nihms951082f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ec8/5926793/969145db710e/nihms951082f7.jpg

相似文献

1
Loss of KLHL6 promotes diffuse large B-cell lymphoma growth and survival by stabilizing the mRNA decay factor roquin2.KLHL6 的缺失通过稳定 mRNA 降解因子 roquin2 促进弥漫性大 B 细胞淋巴瘤的生长和存活。
Nat Cell Biol. 2018 May;20(5):586-596. doi: 10.1038/s41556-018-0084-5. Epub 2018 Apr 25.
2
KLHL6 is a tumor suppressor gene in diffuse large B-cell lymphoma.KLHL6 是弥漫性大 B 细胞淋巴瘤中的一种肿瘤抑制基因。
Cell Cycle. 2019 Feb;18(3):249-256. doi: 10.1080/15384101.2019.1568765. Epub 2019 Jan 24.
3
PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation.PTPN14 通过酪氨酸去磷酸化调节 Roquin2 的稳定性。
Cell Cycle. 2018;17(18):2243-2255. doi: 10.1080/15384101.2018.1522912. Epub 2018 Sep 25.
4
Disruption of KLHL6 Fuels Oncogenic Antigen Receptor Signaling in B-Cell Lymphoma.KLHL6 缺失促进 B 细胞淋巴瘤中癌基因受体信号转导。
Blood Cancer Discov. 2024 Sep 3;5(5):331-352. doi: 10.1158/2643-3230.BCD-23-0182.
5
Regulation of B cell receptor-dependent NF-κB signaling by the tumor suppressor KLHL14.肿瘤抑制因子 KLHL14 对 B 细胞受体依赖性 NF-κB 信号的调节。
Proc Natl Acad Sci U S A. 2020 Mar 17;117(11):6092-6102. doi: 10.1073/pnas.1921187117. Epub 2020 Mar 3.
6
Targeting the hexosamine biosynthetic pathway and O-linked N-acetylglucosamine cycling for therapeutic and imaging capabilities in diffuse large B-cell lymphoma.靶向己糖胺生物合成途径和O-连接的N-乙酰葡糖胺循环以实现弥漫性大B细胞淋巴瘤的治疗和成像功能。
Oncotarget. 2016 Dec 6;7(49):80599-80611. doi: 10.18632/oncotarget.12413.
7
Expression, purification, and microscopic characterization of the tumor suppressor KLHL6.KLHL6 肿瘤抑制因子的表达、纯化和微观特性分析。
Protein Expr Purif. 2023 Oct;210:106318. doi: 10.1016/j.pep.2023.106318. Epub 2023 Jun 5.
8
CRL3-SPOP ubiquitin ligase complex suppresses the growth of diffuse large B-cell lymphoma by negatively regulating the MyD88/NF-κB signaling.CRL3-SPOP 泛素连接酶复合物通过负调控 MyD88/NF-κB 信号抑制弥漫性大 B 细胞淋巴瘤的生长。
Leukemia. 2020 May;34(5):1305-1314. doi: 10.1038/s41375-019-0661-z. Epub 2019 Nov 27.
9
Targeting Non-proteolytic Protein Ubiquitination for the Treatment of Diffuse Large B Cell Lymphoma.靶向非蛋白水解性蛋白质泛素化用于治疗弥漫性大B细胞淋巴瘤
Cancer Cell. 2016 Apr 11;29(4):494-507. doi: 10.1016/j.ccell.2016.03.006.
10
Effect of BCLAF1 on HDAC inhibitor LMK-235-mediated apoptosis of diffuse large B cell lymphoma cells and its mechanism.BCLAF1 对 HDAC 抑制剂 LMK-235 介导的弥漫性大 B 细胞淋巴瘤细胞凋亡的影响及其机制。
Cancer Biol Ther. 2018;19(9):825-834. doi: 10.1080/15384047.2018.1472188. Epub 2018 Jul 3.

引用本文的文献

1
Audit of B-cell cancer genes.B细胞癌基因的审计。
Blood Adv. 2025 Apr 22;9(8):2019-2031. doi: 10.1182/bloodadvances.2022009461.
2
Prevention and treatment of peri-implant fibrosis by functionally inhibiting skeletal cells expressing the leptin receptor.通过功能抑制表达瘦素受体的成骨细胞来预防和治疗种植体周围纤维化。
Nat Biomed Eng. 2024 Oct;8(10):1285-1307. doi: 10.1038/s41551-024-01238-y. Epub 2024 Jul 31.
3
Disruption of KLHL6 Fuels Oncogenic Antigen Receptor Signaling in B-Cell Lymphoma.KLHL6 缺失促进 B 细胞淋巴瘤中癌基因受体信号转导。

本文引用的文献

1
KLHL6 Is Preferentially Expressed in Germinal Center-Derived B-Cell Lymphomas.KLHL6在生发中心来源的B细胞淋巴瘤中优先表达。
Am J Clin Pathol. 2017 Nov 20;148(6):465-476. doi: 10.1093/ajcp/aqx099.
2
Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma.弥漫性大B细胞淋巴瘤的遗传和功能驱动因素
Cell. 2017 Oct 5;171(2):481-494.e15. doi: 10.1016/j.cell.2017.09.027.
3
RNA-binding proteins in immune regulation: a focus on CCCH zinc finger proteins.免疫调节中的RNA结合蛋白:聚焦于CCCH锌指蛋白
Blood Cancer Discov. 2024 Sep 3;5(5):331-352. doi: 10.1158/2643-3230.BCD-23-0182.
4
Altered Metabolism and Inflammation Driven by Post-translational Modifications in Intervertebral Disc Degeneration.翻译后修饰驱动的椎间盘退变中的代谢改变与炎症反应
Research (Wash D C). 2024 Apr 5;7:0350. doi: 10.34133/research.0350. eCollection 2024.
5
Regulation of inflammatory diseases via the control of mRNA decay.通过控制信使核糖核酸衰变来调节炎症性疾病。
Inflamm Regen. 2024 Mar 15;44(1):14. doi: 10.1186/s41232-024-00326-5.
6
The molecular map of CLL and Richter's syndrome.慢性淋巴细胞白血病和里希特综合征的分子图谱。
Semin Hematol. 2024 Apr;61(2):73-82. doi: 10.1053/j.seminhematol.2024.01.009. Epub 2024 Jan 23.
7
A Tandem-Affinity Purification Method for Identification of Primary Intracellular Drug-Binding Proteins.一种用于鉴定原发性细胞内药物结合蛋白的串联亲和纯化方法。
ACS Chem Biol. 2024 Feb 16;19(2):233-242. doi: 10.1021/acschembio.3c00570. Epub 2024 Jan 25.
8
DLBCL-associated NOTCH2 mutations escape ubiquitin-dependent degradation and promote chemoresistance.DLBCL 相关的 NOTCH2 突变逃避泛素依赖的降解并促进化疗耐药性。
Blood. 2023 Sep 14;142(11):973-988. doi: 10.1182/blood.2022018752.
9
Genomic and Transcriptional Profiles of () Gene Family in Polyploid Complex.多倍体 复合体中 () 基因家族的基因组和转录组特征。
Int J Mol Sci. 2023 May 6;24(9):8367. doi: 10.3390/ijms24098367.
10
The roles of KLHL family members in human cancers.KLHL家族成员在人类癌症中的作用。
Am J Cancer Res. 2022 Nov 15;12(11):5105-5139. eCollection 2022.
Nat Rev Immunol. 2017 Feb;17(2):130-143. doi: 10.1038/nri.2016.129. Epub 2016 Dec 19.
4
Loss of the HVEM Tumor Suppressor in Lymphoma and Restoration by Modified CAR-T Cells.淋巴瘤中HVEM肿瘤抑制因子的缺失及经改造的嵌合抗原受体T细胞(CAR-T细胞)的恢复作用
Cell. 2016 Oct 6;167(2):405-418.e13. doi: 10.1016/j.cell.2016.08.032. Epub 2016 Sep 29.
5
Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma.NFKBIE 频繁缺失与原发性纵隔 B 细胞淋巴瘤的不良预后相关。
Blood. 2016 Dec 8;128(23):2666-2670. doi: 10.1182/blood-2016-03-704528. Epub 2016 Sep 26.
6
A weighted exact test for mutually exclusive mutations in cancer.一种用于癌症中互斥突变的加权精确检验。
Bioinformatics. 2016 Sep 1;32(17):i736-i745. doi: 10.1093/bioinformatics/btw462.
7
Aberrant PD-L1 expression through 3'-UTR disruption in multiple cancers.多种癌症中通过 3'-UTR 破坏导致的异常 PD-L1 表达。
Nature. 2016 Jun 16;534(7607):402-6. doi: 10.1038/nature18294. Epub 2016 May 23.
8
Non-coding recurrent mutations in chronic lymphocytic leukaemia.慢性淋巴细胞白血病中的非编码重现性突变。
Nature. 2015 Oct 22;526(7574):519-24. doi: 10.1038/nature14666. Epub 2015 Jul 22.
9
RC3H1 post-transcriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-κB pathway.RC3H1在转录后水平调控A20 mRNA,并调节IKK/NF-κB信号通路的活性。
Nat Commun. 2015 Jul 14;6:7367. doi: 10.1038/ncomms8367.
10
Systems-wide analysis of BCR signalosomes and downstream phosphorylation and ubiquitylation.BCR信号小体及下游磷酸化和泛素化的全系统分析
Mol Syst Biol. 2015 Jun 2;11(6):810. doi: 10.15252/msb.20145880.